Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Just sell the company

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Dec 12, 2022 1:55pm

123 Views

Post# 35166591

RE:RE:RE:RE:RE:Just sell the company

No.. I don't agree... we need a leader to take a stand and pound the table at some point... and we are way passed that point. We need a board to take a stand. Yes we have 6 days in a row of RSI in the 20s and tax loss and son on but... we need a leader we do not have atm... we need a board we do not have atm... if they are tell me where... playing gold in Florida.

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment